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Abstract Facial shape is the basis for facial recognition and categorization. Facial features
reflect the underlying geometry of the skeletal structures. Here, we reveal that cartilaginous nasal
capsule (corresponding to upper jaw and face) is shaped by signals generated by neural structures:
brain and olfactory epithelium. Brain-derived Sonic Hedgehog (SHH) enables the induction of nasal
septum and posterior nasal capsule, whereas the formation of a capsule roof is controlled by
signals from the olfactory epithelium. Unexpectedly, the cartilage of the nasal capsule turned out
to be important for shaping membranous facial bones during development. This suggests that
conserved neurosensory structures could benefit from protection and have evolved signals
inducing cranial cartilages encasing them. Experiments with mutant mice revealed that the genomic
regulatory regions controlling production of SHH in the nervous system contribute to facial
cartilage morphogenesis, which might be a mechanism responsible for the adaptive evolution of
animal faces and snouts.
DOI: https://doi.org/10.7554/eLife.34465.001
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Introduction
The shape of a face strongly depends on the geometry of skeletal elements directly under the skin,
adipose tissue and muscles. Our adult cranial and, in particular, facial skeleton consists mostly of
bony elements. Cartilaginous parts are rather minor. However, during embryonic development bone
forms after the cartilage, and the initial phases of facial and skull shaping proceed with the cartilagi-
nous skeleton only. The entire functional and evolutionary meaning of the chondrocranium, that is,
the early cartilaginous elements of the embryonic skull, is not clear. Some parts of the chondrocra-
nium will undergo endochondral ossification (for example, pre-sphenoid and basisphenoid, cribri-
form plate, Meckel´s cartilage, olfactory septum, nasal concha, labyrinth of ethmoid, vomer and
tympanic bulla). However, the majority of the bones, especially in a facial compartment, will form in
a close spatial association with the chondrocranium independently through dermal membranous
ossifications (Carson, 1999). Many questions, including how and from where molecular signals con-
trol the complex chondrocranial shape, and whether the geometry of the chondrocranium directs
the shape of facial bones, are still unanswered.
Achondroplasia, a rare disease due to cartilage insufficiency, includes craniofacial malformations
such as protruding forehead, low nasal bridge, maxillary hypoplasia, problems in the otolaryngeal
system and macrocephaly as well as foramen magnum stenosis (Shirley and Ain, 2009). Prominent
human and mouse achondroplasia phenotypes based on Fgfr3 mutations suggest that a correctly
shaped chondrocranium is essential for proper facial bone geometry and general facial outgrowth.
However, Fgfr3 is expressed also at membranous ossification sites (please see Fgfr3(mRNA) expres-
sion at E15, http://developingmouse.brain-map.org/), as well as in sutural osteogenic fronts
(Ornitz and Marie, 2002). Therefore, models involving Fgfr3 do not allow for precise discrimination
of cartilage or bone-dependent parts of the phenotype in affected subjects. Still, these effects
strongly suggest that chondrocranium shape might be truly important for producing initial facial
geometry and for influencing the formation of membranous bone on top of the cartilaginous
template.
The facial chondrocranium is built by neural crest cells that populate the frontal part of the head
and undergo multilineage differentiation. They give rise to cartilage, bone, fascia, adipose tissue,
smooth muscle, pericytes, glia and neurons (Snider and Mishina, 2014; Baggiolini et al., 2015). Par-
axial mesoderm also contributes to the chondrocranium in posterior basicranial and occipital loca-
tions. Collective behavior and differentiation of the neural crest and neural crest-derived
ectomesenchyme is largely responsible for the future shape of the face (Minoux and Rijli, 2010).
However, the precise mechanisms governing this collective behavior, cartilage induction and shape-
making are not fully understood, despite significant progress in the research field of cartilage and
bone formation.
McBratney-Owen and Morris-Key with coworkers demonstrated that the complete chondrocra-
nium (including the base of the skull) develops from 14 pairs of independently induced large cartilag-
inous elements that fuse together during later development (McBratney-Owen et al., 2008).
Sculpting perfect geometries of such cartilaginous elements is a key developmental and regenera-
tive process that accounts for the shape and integrity of our body. Current opinion holds that carti-
lage forms from condensing mesenchymal cells that are destined to become chondrocytes
(Ornitz and Marie, 2002). Mesenchymal condensations emerge in specific locations. Here, they
somehow become shaped, grow and turn into cartilage that later expands until the initiation of
endochondral or membranous ossification.
The frontonasal prominence and other facial regions are enriched in signaling systems. Activity in
these systems leads to progressive induction and shaping of craniofacial structures, including chon-
drogenic mesenchymal condensations that turn into cartilage (Minoux and Rijli, 2010). The signaling
center located in the most anterior face, the so called FEZ (Frontonasal Ectodermal Zone), produces
Sonic Hedgehog (SHH) and Fibroblast growth factor 8 (FGF8), which play important roles in facial
shaping. FGF8, SHH and Bone Morphogenetic Proteins (BMPs) produced by FEZ regulate the behav-
ior of ectomesenchymal tissue and participate in positioning of chondrogenic condensations inside
of the embryonic face (Foppiano et al., 2007; Hu et al., 2015b; Young et al., 2014). The mecha-
nisms of facial cartilage induction that involve these molecules have received particular attention dur-
ing recent years (Gros and Tabin, 2014; Abzhanov and Tabin, 2004; Bhullar et al., 2015;
Griffin et al., 2013).
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Another recent breakthrough brought up the fact that the brain itself can emit signals that influ-
ence facial shaping. Expression of Shh in the forebrain turned out to be important for the correct for-
mation of FEZ and early steps of facial shaping in general (Hu et al., 2015a; Chong et al., 2012).
Still, how these and other signaling centers synchronize in order to build the 3D shape of facial
cartilaginous elements is not understood. The cartilaginous nasal capsule is the most anterior part of
the chondrocranium. Together with Meckel’s cartilage in the lower jaw, it constitutes an excellent
model system to address questions concerning cartilage induction and shaping.
Here, using mild ablations of cartilage with tightly controlled genetic tools, we revealed that the
shape of the nasal capsule is a key for the geometry and positioning of the facial bones and overall
facial shape. Subsequently, with the help of numerous mouse mutants, specific contrasting techni-
ques and micro-CT, we demonstrated that signaling centers in the developing brain and olfactory
epithelium jointly and independently enable the induction of the nasal capsule in the embryonic
face. Various genomic regulatory regions that direct the expression of Shh to the developing ner-
vous system participate in the fine-tuning of the shape of the facial cartilaginous skeleton.
Results
Taking into account known achondroplasia facial phenotypes, we hypothesized that even minor
changes in the facial cartilaginous template may lead to significant or even major changes in the
overlaying membranous bone geometry and the overall facial shape. Thus, we performed mild time-
controlled genetic ablation of early chondrocytes employing Col2a1-CreERT2/R26DTA mice and
analyzed their facial development (Figure 1). We used a dose of 2.5 mg of tamoxifen administered
at E12.5 and, in an alternative experiment, double injection at E13.5-E14.5 to avoid a strong pheno-
type with dramatic face shortening and brain shape distortion, and we analyzed the mutant embryos
at E17.5 and E15.5 correspondingly (Figure 1). Col2a1-CreERT2 is a well-established tool to target
facial chondrocytes and their immediate progenitors. Tamoxifen was administered at early stages of
facial development where no bone is present. Also, this CreERT2 line does not recombine in osteo-
blasts or their progenitors in membranous ossification sites and, thus, cannot directly impinge on
them (Figure 1A–D). Despite only mild cartilage reduction (mean 30,7% of the cartilage surface
decrease at E15.5 and mean 35,2% at E17.5), the facial compartment of the Col2a1-CreERT2+/-/
R26DTA+/-embryos appeared massively affected with short snout and distorted membranous ossifi-
cations (Figure 1E–R). Interestingly, the forming mandibular bone appeared shortened and widened
at the same time, which cannot be explained only by the shortening of Meckel’s cartilage (Figure 1—
figure supplement 1). This fact suggests an interplay between cartilage and membranous bone that
might involve signal-guided rearrangements in skeletogenic tissues. Thus, genetic ablations of
COL2A1-producing pre-chondrocytes and chondrocytes revealed a different degree of cartilage loss
in the nasal capsule and Meckel’s cartilage, together with corresponding incremental dysmorpholo-
gies of membranous bones and face in general. These slight differences in the strength of the phe-
notype are likely attributed to the fine diversity of developmental stages within one litter receiving
tamoxifen during a single injection into a mother (Figure 1Q–R and Figure 1—figure supplement
1). Thus, the geometry of the face and corresponding bony structures depend on the correct induc-
tion and shaping of a facial cartilage. This, in turn, is largely established at the level of chondrogenic
mesenchymal condensations, as we recently demonstrated (Kaucka et al., 2017). It is worth empha-
sizing that according to our previous study, the chondrogenic condensations are induced being pre-
shaped (Kaucka et al., 2017).
Consequently, we decided to analyze the molecular signals and their sources that induce these
geometrically complex condensations. Several molecules were reported to have an impact on the
cartilage induction, either on the condensation placement or on proper timing of cartilage-forming
events (Goldring et al., 2006). Among those, SHH was shown to play a key role in the spatio-tempo-
ral induction of chondrogenic mesenchymal condensations (Abzhanov and Tabin, 2004;
Billmyre and Klingensmith, 2015; Park et al., 2010). We analyzed the expression of Shh in early
and late developing mouse face with the help of the Shh-Cre/GFP (B6.Cg-Shhtm1(EGFP/cre)Cjt/J)
model, and found that Shh is expressed in very discrete regions of the face between E11.5 and
E14.5 at the time of induction of facial cartilages (Figure 2 and Figure 2—figure supplement 1). At
the early stages (E11.5 and E12.5, see Figure 2A–B), the SHH + regions included forming olfactory
epithelium (magenta), dental and oral epithelium (red), eyes (cyan) and brain (yellow). Interestingly,
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Figure 1. Correct chondrocranium development is essential for shaping the embryonic face. (A–C) Genetic tracing induced at E12.5 in Col2a1-
CreERT2/R26Confetti shows recombination in chondrocytes (B) only and not in a lineage of membranous bone osteoblasts and their progenitors (C), 25
mm cryo-sections (A–D, G–H) were imaged with a confocal microscope (A–C) or phase contrast microscope (D, G–H). (D) Traced sections have been
stained using Alcian Blue (cartilage, blue) and von Kossa (brown, mineralized tissue). (E–F) Wild type (E) and Col2a1-CreERT2/R26DTA (F) embryos with
Figure 1 continued on next page
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only certain regions of olfactory epithelium were SHH+ (see stained cryosections under the 3D mod-
els in Figure 2). Later on (at E13.5 and E14.5 – Figure 2—figure supplement 1), we detected addi-
tional SHH-producing structures such as whiskers (blue-green), tongue (not segmented) and salivary
Figure 1 continued
cartilage being partially ablated as a result of tamoxifen injection (2.5 mg) at E12.5, both analyzed at E17.5. (G–H) Sagittal sections of the anterior head
from wild type (G) and Col2a1-CreERT2/R26DTA (H) embryos stained with Alcian Blue (blue, stains for cartilage) and von Kossa staining (black, stains for
mineralized bone tissue). Olfactory system is outlined by green dashed line for better orientation. Note that physiological growth of the cartilage sets
the proper size of the facial compartment. (I–O) 3D-reconstructions of frontal chondrocranium together with bone and teeth primordia in control (I, L,
M) and cartilage-ablated (J, N, O) embryos. (K) Best fit comparison of control (red) and cartilage-ablated (light green) 3D chondrocranium models. (P)
3D-reconstruction of frontal chondrocranium and formed cartilage including GOM Inspect software analysis of the mutant bone (Q) overview of
analyzed mutants (injected with low dose of tamoxifen (2.5 mg) at both E13.5 and E14.5 and analyzed at E15.5) and formed bone in one representative
control and three mutants (R) Bar-graphs showing the manual 3D segmentation of the surface area of cartilage. Data are obtained from three control
samples and three mutant mice for (E15.5) and three control samples and one mutant sample with the most pronounced phenotype for (E17.5). The
error bars show mean and standard deviation (SD). For the comparison, we used unpaired Student t-test (95% confidence interval  9974138 to
 6056665). Raw data are available in Figure 1—source data 1.
DOI: https://doi.org/10.7554/eLife.34465.002
The following source data and figure supplement are available for figure 1:
Source data 1. Raw values of cartilage surface measurments corresponding to Graph in Figure 1R.
DOI: https://doi.org/10.7554/eLife.34465.004
Figure supplement 1. Mild ablation of cartilage using Col2a1-CreERT2/R26DTA.
DOI: https://doi.org/10.7554/eLife.34465.003
Figure 2. Shh is expressed through the early facial development in distinct regions of the head. The expression pattern of Shh during developmental
stages E11.5 (A) and E12.5 (B) in B6.Cg-Shhtm1(EGFP/cre)Cjt/J, segmented Shh-expression regions are color-coded and clarified in legend (C).
Immunohistochemical (IHC) staining shows olfactory neuroepithelium and newly formed mesenchymal condensation as ERBB3 positive. White arrows
point at GFP-expressing parts of various tissues. Red rectangle in (A) and (B) upper panel mark the olfactory neuroepithelium, yellow rectangle in (B)
shows area magnified in the right bottom corner. White dotted line outlines the shape of mesenchymal condensation. IHC staining was performed on
20 mm cryosections and imaged using a confocal microscope.
DOI: https://doi.org/10.7554/eLife.34465.005
The following figure supplement is available for figure 2:
Figure supplement 1. Shh is expressed through the later facial development in distinct regions of the head.
DOI: https://doi.org/10.7554/eLife.34465.006
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gland (blue). We assumed that there is a prerequisite for a certain minimal distance between Shh-
expressing structures and forming cartilage of nasal capsule that enables the secreted molecule to
reach the target and impose chondrogenic stimuli on mesenchymal cells. According to our results,
the most probable pro-chondrogenic SHH-emitting structures in the face were the olfactory epithe-
lium and the forebrain.
To test if SHH emitted by these structures controls nasal capsule induction or influences its geo-
metrical features, we analyzed a series of mouse mutants with a micro-CT-based 3D-visualization
approach. To perform these 3D visualizations of the mesenchymal chondrogenic condensations, car-
tilage and bone, we utilized a soft tissue contrasting with phosphotungstic acid (PTA) followed by
micro-CT scanning. Chelation of tungsten is uneven in various cell types and creates reliable contrast
highlighting different tissues.
Firstly, to address whether the induction of distinct elements of the facial chondrocranium is not
only timely regulated, but also has a discrete spatial aspect related to various sources of inductive
signals, we genetically ablated Shh in the brain to test its role in facial cartilage induction. For this,
we took advantage of Nkx2.2-Cre/Shh floxed/floxed animals to delete Shh in the floor plate cells since
the beginning of central nervous system (CNS) development and patterning. We analyzed two differ-
ent stages: E12.5 as a stage of condensations of cartilaginous mesenchyme (Figure 3 and Figure 3—
figure supplement 1 ‘Interactive PDF’) and E15.5 as a later stage of nearly fully formed chondrocra-
nium with its rather final shape (Figure 3 and Figure 3—figure supplement 1 ‘Interactive PDF’).
This experiment resulted in an unexpected phenotype. It included a selective loss of a nasal septum
together with heavily affected posterior part of the nasal capsule as detected at E12.5 (Figure 3B–C,
E–F). The chondrogenic condensation corresponding to a forming septum failed completely,
whereas the condensation of the posterior part of nasal capsule appeared incompletely induced.
Additional changes were detected in the facial cartilage at E15.5, mainly represented by the missing
midline groove (Figure 3G–H) and the absence of the very anterior part of nasal cartilage
(Figure 3H). Additional changes included various malpositioned parts, fused nerve foramina and var-
iations in shaping and bending of cartilage elements, as summarized in Figure 3. Notably, the
mutant embryos analyzed at E12.5 and E15.5 presented with cleft palate. This could indicate that
some clinical cleft palate cases might have their origin in disturbed brain-derived signaling (Fig-
ure 3—figure supplement 2).
At the same time, the general geometry of the frontal part of facial chondrocranium remained
almost unperturbed, thus, supporting the spatial modularity of cartilage induction in the face. The
microstructure of the cartilage stayed normal, with fine borders defining bent cartilaginous sheets
forming the major structure of the nasal capsule. The thickness of the cartilaginous sheets forming
the capsule also remained comparable to that found in littermate controls (Figure 3J). These obser-
vations strongly suggested that the early stages of cartilage induction must be affected.
We also investigated bone formation in the area of the nasal capsule at E15.5 (Figure 3I). We
observed missing parts in maxillary bones from mutants, and malpositioned incisors that were found
more posteriorly on top of instead of being in the anterior part of the maxilla. At this stage and in
this particular location, there was no endochondral ossification ongoing. However, according to
micro-CT data, the bone was forming in the proximity and on top of the existing cartilaginous shape
template. Thus, the facial chondrocranium is important for the correct formation of the membranous
facial bones.
Recently it has been shown that the brain can influence facial shaping via Shh, acting presumably
on the frontonasal ectodermal signaling zone (abbreviated as FEZ) (Hu et al., 2015a; Chong et al.,
2012). It is currently believed that FGF8, SHH and BMPs produced by FEZ regulate the behavior of
ectomesenchymal tissue and participate in positioning of chondrogenic condensations inside of the
embryonic face (Foppiano et al., 2007; Hu et al., 2015b; Young et al., 2014). However, our data
show that SHH emitted from the forebrain mostly affects the basicranial, posterior and septal parts
of the facial chondrocranium without strong effects on the most anterior nasal capsule (including
other soft tissues in general), which could be expected if the effects of a brain-derived SHH are
entirely mediated by FEZ. Importantly, the major geometric structure of the mutant brain stays
largely unchanged although it appears reduced in size. Thus, changes in brain shape are not likely to
cause very selective influences on forming facial structures due to mere mechanical interactions (Fig-
ure 3—figure supplement 3).
Kaucka et al. eLife 2018;7:e34465. DOI: https://doi.org/10.7554/eLife.34465 6 of 27
Research article Developmental Biology Stem Cells and Regenerative Medicine
Figure 3. Shh signal from the brain induces a posterior part of a nasal capsule. (A) Model of overall shape resulting from the excision of Shh from the
floor plate using Nkx2.2-Cre/Shhfloxed/floxed shows visible phenotype in the E12.5 mutant embryo comprising, for instance, from the cleft of upper lip,
non-prominent or missing nasal vestibule and diminished curvature of the snout. (B–C, E–F) micro-CT scans-based 3D reconstructions of chondrogenic
mesenchymal condensations in E12.5 mutant and control embryos. Note the missing posterior part of the developing nasal capsule and the missing
Figure 3 continued on next page
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Finally, we analyzed the spinal column of the mutants and control embryos and found localized
shape defects in the cervical vertebrae represented by incomplete transverse foramina (foramina
transversariae) (Figure 3—figure supplement 4). Notably, the defects in the nasal septum stayed
confined only to the cartilage as a tissue. The septal chondrogenic condensations and cartilage were
missing as apparent E12.5 and E15.5, whereas the soft tissues of the septum stayed in place (Fig-
ure 3—figure supplement 4). Similarly, despite the cartilage defects clearly identified in spinal col-
umn, the other tissue types that were in close proximity to the defects did not show any difference
from control. For instance, the vertebral arteries traversing the distorted cartilage of the transverse
foramina appeared unaffected in Nkx2.2-Cre/Shh floxed/floxed animals (Figure 3—figure supplement
4).
Next, we determined the Shh expression in the forming olfactory epithelium and tested the role
of the forming olfactory epithelium and olfactory neurons in the process of nasal capsule induction.
The possibility that olfactory epithelium controls cartilage shaping is supported by the fact that the
conchae of nasal labyrinth geometrically correlate with the folded structure of the olfactory epithe-
lium, which they mechanically support.
A desired experimental setup that would allow us to target and genetically delete Shh from the
olfactory epithelium does not exist. To define the importance of any signal derived from the olfac-
tory epithelium we utilized Six1 and Six4 double knockout to specifically ablate the development of
the olfactory epithelium (Ikeda et al., 2007; Kobayashi et al., 2007). We analyzed Six1/4 double
mutant embryos at E18.5, that showed no olfactory structures, using the micro-CT method and per-
formed a thorough comparison to wildtype littermates (Figure 4 and Figure 3—figure supplement
1 ‘Interactive PDF’). In these mutants which had markedly shortened noses, the roof of the nasal cap-
sule was entirely missing. However, the septum and the posterior part of the capsule were relatively
well-preserved (Figure 4B–D). An earlier analysis at E12.5, a stage when the majority of facial chon-
drogenic condensations come into place, showed that in double knockouts, the chondrogenic con-
densation corresponding to the nasal capsule roof is missing. The chondrogenic condensation
corresponding to the nasal septum appeared non-fused at this stage and fused only later, as evident
from E17.5 reconstructions. At the same time, the roof of the nasal capsule was never induced (Fig-
ure 4—figure supplement 1A–D). This is consistent with the prediction that a lack of the olfactory
epithelium will prevent the induction of olfactory cartilages. Analyses of the bones showed a major
change in the overall geometry, with prominent shortening along the anterior-posterior axis (brachy-
cephalic-like appearance). Furthermore, we noticed a lack of mandibular incisors and an obvious
asymmetry between left and right parts of the maxilla (Figure 4E,J).
In addition to the expression in olfactory placodes, Six1 and Six4 are expressed in different parts
of early facial mesenchyme (Kobayashi et al., 2007; Grifone et al., 2005). The full knockout of Six4
does not show any phenotype according to previously published data (Ozaki et al., 2001). We
Figure 3 continued
septum in the mutant. (D) best-fit computed comparison of the overall shape and size of mutant and control embryo. (G–H) 3D models of
chondrocrania of mutant (Nkx2.2-Cre/Shhfloxed/floxed) and control embryo, analyzed at E15.5. Among the main differences are missing frontal part of
nasal cartilage, missing lateral parts of developing nasal capsule, malpositioned asymmetric cartilage, not fully closed foramina for pervading nerves
and vasculature and various disconnected cartilaginous segments. (I) Segmented cartilage and bones projected in the overall shape of the head of
mutant (bottom) and control (upper) embryo. Note the malpositioned incisors in the maxilla of the mutant and missing part of the frontal nasal capsule
formed by the bone. (J) Wall thickness analysis of the cartilages in the E15.5 head of mutant (bottom) and control (upper) embryo show no evident
differences in the thickness of formed cartilage.
DOI: https://doi.org/10.7554/eLife.34465.007
The following figure supplements are available for figure 3:
Figure supplement 1. ‘Interactive PDF’.
DOI: https://doi.org/10.7554/eLife.34465.008
Figure supplement 2. Ablation of Shh from the floor plate results in the cleft palate.
DOI: https://doi.org/10.7554/eLife.34465.009
Figure supplement 3. Brain volume and overall anatomy in mutants with Shh genetically deleted from the floor plate of the developing CNS.
DOI: https://doi.org/10.7554/eLife.34465.010
Figure supplement 4. Phenotypic manifestation of Shh genetic ablation from the floor-plate, analyzed at E15.5 upper part of spine.
DOI: https://doi.org/10.7554/eLife.34465.011
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Figure 4. Signals from the olfactory epithelium induce the anterior part of the nasal capsule. (A–J) Six1/Six4 double knock out mouse embryo
compared to littermate control and analyzed at E18.5 using micro-CT and 3D-reconstruction. (A, E, K) overall shape and size of the mutant head is
different from the control head, showing brachycephalic phenotype, bulging eyes, misshaped earlobes positioned more frontal and lower than the
control embryo (F, J, K). Note also the left-right asymmetry of the snout of the mutant. (B, G) Wall thickness analysis of mutant (B) and control (G)
embryo. (C, H) single plane from raw CT data shows missing olfactory neuroepithelium in the Six1/Six4 double mutant and control. Note also missing
nasal capsule but retained septum in the mutant. (D–E, I–J) various views on segmented 3D model of chondrocranium of mutant (D–E) and control (I–J)
embryo. Among the obvious differences are missing roof and lateral parts of nasal capsule while the septum is preserved. (L) Six1 single knock out
mouse embryo analyzed at E18.5 using micro-CT 3D reconstruction (M) single plane cross-sections from raw CT of Six1 single knock out E18.5 embryo.
DOI: https://doi.org/10.7554/eLife.34465.012
Figure 4 continued on next page
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therefore analyzed the full knockout of Six1, in which the olfactory epithelium is present, to see
whether it will show a mesenchyme-driven phenotype in the nasal capsule roof. The analysis of E18.5
Six1-/- embryos demonstrated the presence of the nasal capsule roof as well as a septum. The phe-
notype in Six1-/- embryos mostly included a narrowing of the posterior nasal capsule with mild septal
defects (Figure 4L–M and Figure 4—figure supplement 1E).
This experiment provided a complementary, non-overlapping phenotype to the one with a nasal
capsule resulting from the excision of Shh from the floor plate (Nkx2.2-Cre/Shhfloxed/floxed). This sug-
gests that solid cartilage elements in the forming face depend on joint activities of multiple regula-
tory zones (sources of SHH) during their induction and shaping.
To investigate if sensory neurons in the olfactory neuro-epithelium might be potential sources of
SHH, we utilized Ascl1 (Mash1) knock-out embryos (Figure 4—figure supplement 2). In these ani-
mals, major neurogenic transcriptional factor essential for olfactory neuron formation are missing,
and very few olfactory sensory neurons are generated (Guillemot et al., 1993; Cau et al., 1997).
We analyzed craniofacial structures in these mutants and found out that they did not demonstrate
any gross abnormality despite their inability to develop large amounts of olfactory neurons. Hence,
the sensory olfactory neurons are not critical cartilage-inducing sources, while the early olfactory epi-
thelium, before the neurogenesis, is important for the formation of chondrogenic mesenchymal
condensations.
To check if SHH from the brain and presumably from the olfactory epithelium acts directly on
facial mesenchyme inducing chondrogenic differentiation or during cartilage growth, we analyzed
embryos carrying a SHH-activity reporter GBS-GFP (Balaskas et al., 2012) at different developmen-
tal stages ranging from E9 to E14.5. The GFP signal was detectable as expected in the forming pal-
ate, brain, spinal cord and tissues that are known to receive SHH input. However, we did not
observe GBS-GFP activity in the chondrogenic mesenchymal condensations from the earliest chon-
drogenic stages E11.5-E12.5 onwards (Figure 5A). Consistently with this, lineage tracing in Gli1-
CreERT2/R26Tomato mice injected with tamoxifen at E11.5 and analyzed at E17.5 showed sporadic
patches of traced chondrocytes in the facial cartilages (Figure 5B). If the injection of tamoxifen was
performed at E12.5 or later, these sporadic patches of labeled chondrocytes disappeared; that is we
observed only very rarely scattered chondrocytes in other locations (Figure 5B–C). Analysis of the
rare individual clones of chondrocytes resulting from labeling at E11.5 in Gli1-CreERT2/R26Confetti
demonstrated that mesenchymal cells turn into chondroprogenitors that divide several times to gen-
erate clonal clusters of mature chondrocytes (Figure 5C–D). At later stages of tamoxifen administra-
tion, this was not observed, which is consistent with analysis of Gli1-LacZ embryos at E12.5, where
the X-gal staining was confined to whisker pads and other peripheral locations. In situ hybridization
(RNAscope) for other components of the Hedgehog pathway (including Ptch1(mRNA), Ptch2
(mRNA), Gli1(mRNA), Gli2(mRNA)) showed no enrichment within potential and actual chondrogenic
areas (Figure 5—figure supplement 1). To functionally test if inhibition of SHH at chondrogenic
stages will affect the development of facial cartilage, we administered SHH-inhibitor vismodegib
(LoRusso et al., 2011) at either E11.5, E12.5, or E13.5 and analyzed the embryos at E15.5. In line
with predictions from expression analysis and SHH-activity reporter, we did not find striking abnor-
malities in nasal and Meckel´s cartilages from all treated and analyzed embryos (n = 4) (Figure 6A).
At the same time, we observed the absence of palate and concomitant abnormalities in whiskers dis-
tributions in E11.5-to-E15.5 and E12.5-to-E15.5 stages of treatment, but not in E13.5-to-E15.5
stages. Indeed, in embryos treated between E11.5 and E12.5, the palatal shelves were severely
reduced or missing (Figure 6A–C). This showed that SHH signaling in these embryos was inhibited
to significant extents and also suggested that the action of SHH on patterning of the nasal capsule
precedes the stage of chondrogenic condensations.
Figure 4 continued
The following figure supplements are available for figure 4:
Figure supplement 1. Analysis of mesenchymal condensations in Six1/Six4 double knock out embryos at E12.5.
DOI: https://doi.org/10.7554/eLife.34465.013
Figure supplement 2. Ascl1 knockout embryo analyzed at E16.5 does not show any significant changes in formed nasal capsule.
DOI: https://doi.org/10.7554/eLife.34465.014
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Consistent with these results, which suggest an early pre-chondrogenic role of SHH signaling on
nasal capsule patterning, the analysis of embryos homozygous for a hypomorphic Shh allele (Shh-
GFP, here referred to as ShhHypo), in which SHH signaling is constitutively reduced (Zagorski et al.,
2017; Chamberlain et al., 2008), revealed severe abnormalities in the facial cartilage (Figure 6D
and Figure 6—figure supplement 3). The results of all genetic perturbations and treatments with
drugs as well as their comparative phenotypes are summarized in Figure 7. Taken together, the
effects of SHH on chondrogenic differentiation in the facial region are early and precede the first
wave of chondrocyte differentiation that occurs between E11.5 and E14.5. These results are also
consistent with the phenotype of Six1/Six4 double knockout embryos at E12.5 (Figure 4), and cor-
roborate the notion of an early pre-cartilage onset of the phenotype.
Tissue-specific expression of Shh is known to be controlled by multiple enhancers. Some, which
may regulate Shh expression in the cranial region, have been characterized (Yao et al., 2016;
Jeong et al., 2006; Sagai et al., 2009). To modulate Shh expression in different craniofacial regions,
we analyzed mutant mice carrying different rearrangements (deletions or inversions) with impacts on
the distal regulatory landscape of Shh (Symmons et al., 2016). We paid specific attention to
Figure 5. Mapping of the expression of Gli1 and Shh signaling activity in mouse embryonic head. (A) Mapping of the activity of the SHH signaling in
mouse embryonic head at E11.5, E12.5 and E13.5 prechondrogenic and early chondrogenic stages using GBS-GFP activity reporter. (B) Genetic tracing
using Gli1-CreERT2/R26Tomato induced at E11.5 (upper panel) and E12.5 (bottom panel) and analyzed at E17.5. Dotted line outlines cartilaginous
structures within the nasal capsule. White squares outline the magnified area. DRG = dorsal root ganglion, OLF = Olfactory system, MX = maxillar
prominence, MD = mandibular prominence. TG = trigeminal ganglion. (C) Genetic tracing using Gli1-CreERT2/R26Confetti, induced at E11.5 and
analyzed at E16.5 (left panel) and induced at E14.5 and analyzed at E17.5 (right panel) shows the contribution of Gli1-traced positive cells to the
cartilaginous structures in the embryonic head. (D) Quantification of the contribution of Gli1-traced positive cells to the cartilage. (A–C) 20 mm
cryosections were used for the IHC staining and analysis. A confocal microscope has been used for imaging.
DOI: https://doi.org/10.7554/eLife.34465.015
The following figure supplement is available for figure 5:
Figure supplement 1. Mapping of the presence of major SHH signaling components in the E12.5 embryo.
DOI: https://doi.org/10.7554/eLife.34465.016
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Figure 6. Effect of Vismodegib treatment on the size and structure of nasal cartilage. (A) Panel shows raw CT data, cross-sections from various planes
from DMSO (control treatment), Vismodegib inhibitor administered at E11.5, E12.5 or E13.5, all analyzed at E15.5 (B) Raw CT cross-sections show
absent/disrupted cartilaginous structures in Vismodegib-treated embryos (C) 3D reconstruction and comparison of inhibitor-treated (Vismodegib E11.5-
E15.5) and control (DMSO-treated) embryos and their nasal capsules. Arrows point at differences in anatomy and overall geometry of the nasal capsule.
Graph representation of overall cartilage change of inhibitor-treated embryos. Raw data are available in Figure 6—source data 1. (D) 3D-
reconstruction of the nasal capsule of Shh hypomorph (analyzed at E15.5 and E17.5) including wall thickness analysis.
DOI: https://doi.org/10.7554/eLife.34465.017
The following source data and figure supplements are available for figure 6:
Source data 1. Raw values of cartilage measurements corresponding to Graph in Figure 6C.
DOI: https://doi.org/10.7554/eLife.34465.021
Figure supplement 1. Mutations of various regulatory regions controlling expression of Shh, their positions and effect on chondrogenesis.
DOI: https://doi.org/10.7554/eLife.34465.018
Figure supplement 2. Mutated genomic regions containing regulatory sequences controlling expression of Shh show a variety of similar and dissimilar
phenotypes.
DOI: https://doi.org/10.7554/eLife.34465.019
Figure supplement 3. The effect of reduced SHH signaling on chondrogenesis at E15.5 and E17.5.
DOI: https://doi.org/10.7554/eLife.34465.020
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Figure 7. llustration depicting the timeline of all experiments and the beginning of effects. The results of all genetic perturbations and treatments with
drugs as well as their comparative phenotypes are summarized.
DOI: https://doi.org/10.7554/eLife.34465.022
Kaucka et al. eLife 2018;7:e34465. DOI: https://doi.org/10.7554/eLife.34465 13 of 27
Research article Developmental Biology Stem Cells and Regenerative Medicine
genomic regions where known and potentially unknown brain-specific enhancers (SBE, Shh Brain
Enhancers) are located (Jeong et al., 2006; Sagai et al., 2009). Currently known SBEs (SBE2, SBE3,
SBE4) localize between the Shh coding region and mark 6b (Irimia et al., 2012) (see scheme in Fig-
ure 6—figure supplement 1). Animals carrying an allele with the inversion of a large genomic region
including known SBEs, INV( 500 C1), demonstrated selectively localized mild defects in the nasal
septum and also in the tips of Meckel’s cartilage, but not in the roof of nasal capsule. This septum-
specific phenotype appeared more pronounced in a homozygous INV( 500 C1) as compared to the
heterozygous genotype. Interestingly, this allele does not change the relative position to Shh of
most known enhancers that could be responsible for SHH-dependent facial skeletal development.
The phenotype observed in this experiment showed that septal cartilage is sensitive to minor
changes in SHH patterning signals that result from either removal of regulatory sequences distal to
the C1 position, or indirect effects affecting distant enhancer-promoter- communications.
INV(6b-C2), which removes additional enhancers required for ventral forebrain expression of Shh
in E10.5 embryos (Figure 6—figure supplement 1A–C), showed much stronger phenotypes.
Such strong phenotypes are most likely due to disruption of the Shh TAD (Topologically Associat-
ing Domain), and displacement of major regulatory elements at a position which prevent their inter-
action with Shh (Symmons et al., 2016). Accordingly, Shh expression is much reduced in the
forebrain of mutant embryos at E10.5 as evident from the results of in situ hybridization for Shh (Fig-
ure 6—figure supplement 1A–C).
Heterozygote INV(6b-C2) did cause minor defects in septum, while the same inversion over a full
Shh deficiency (DEL( 90 C2) led to a strong holoprosencephaly similar to ShhHypo (Figure 6 and Fig-
ure 6—figure supplement 2. However, it was not as strong as a full Shh knockout, where only a pro-
boscis is left.
In the mutants INV(6b-C2) x DEL( 90 C2), the nasal septum did not develop at all, and the rest of
the nasal capsule (roof) was present although severely disturbed in shape. The gradual increase in
severity of the malformations from INV( 500 C1) to INV(6b-C2) may indicate the presence of several
distinct enhancers related to face morphology distal to position 6b (which likely includes yet unchar-
acterized enhancers). It could also mean that the efficiency of the interactions of the known
enhancers (SBE2-4) with the Shh promoter is modulated by the presence of distal elements, which
may contribute to organize the Shh TAD (Symmons et al., 2016). Both scenarios suggest the exis-
tence of other regulatory regions important for facial development including new potential SBEs
based on the reduction of the LacZ-based Shh-expression reporter signal in the forebrain of mutant
embryos at E10.5 (Figure 6—figure supplement 1).
DEL(5-8) showed a powerful phenotype similar to the homozygous INV(6b-C2). This, in a combi-
nation with previous phenotypes, reveals that the key regulatory regions essential for the facial carti-
lage patterning are located between marks 6b and C1. These regulatory regions are likely SBEs
since the LacZ expression disappears from the forebrain of reporter embryos at E12.5 according to
previous results (Symmons et al., 2016). DEL(C1-Z) did not show any gross abnormalities in the
nasal capsule cartilage. Embryos carrying this mutation showed abnormal Meckel’s cartilage and a
generally affected mandible.
Taken together, local tuning of SHH expression by various enhancers (including brain-specific reg-
ulatory elements) seemingly controls discrete steps of chondrocranial patterning, which may repre-
sent a key evolutionary mechanism shaping animal snouts and faces.
Discussion
In addition to the obvious functional aspects, facial shape is important in many ways. For example,
recognition of individual facial features assists social interaction and affects numerous important
aspects of our everyday life (Vernon et al., 2014). Pathological conditions include a very wide spec-
trum of deficiencies, and may involve eating, breathing and speech impairments, emotional prob-
lems and low quality of life in general (Forbes, 2010). Here, we demonstrated that even fine and
selective manipulations of a facial cartilage geometry and size (performed in Col2-CreERT2+/-/
R26DTA+ embryos) result in significant changes of adjacent membranous bones and facial shape. In
turn, the facial cartilage geometry is controlled by the signals coming from neurosensory structures
such as brain and olfactory epithelium. Altogether, these results might provide a new explanatory
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framework revealing how the integrated development of neural and non-neural tissues results in the
precise and evolutionary adapted shape of the bony cranium and corresponding facial appearance.
Previously, Marcucio and Hallgrimsson laboratories demonstrated the co-variation of brain and
face as well as the impact of brain-emitted SHH on avian facial development (Hu and Marcucio,
2009; Marcucio et al., 2011; Parsons et al., 2011; Petryk et al., 2015). Yet, the role of such brain-
derived signals in cartilage and bone shaping has not been extensively investigated. According to
our results, SHH, a key signal enabling cartilage induction, arrives from the floorplate of the brain,
and the selective ablation of Shh in that area by non-inducible Nkx2.2-Cre causes a highly selective
loss of the nasal septum cartilage. The soft non-cartilaginous tissue of the nasal septum, however,
remains intact, rendering this part of the phenotype highly cartilage-specific. The roof of the nasal
capsule stays nearly unaffected. The analysis at E12.5 stage suggested that this phenotype must be
related to pre-chondrogenic, early SHH-dependent patterning signals enabling cartilage formation.
This reasoning is further supported by the line of experiments involving ‘early on action’ ShhHypo
embryos, which demonstrated a profound phenotype in the nasal capsule cartilage. This was in con-
trast to wild type embryos treated with the SHH-inhibitor Vismodegib strictly between chondrogenic
stages (E11.5-E13.5). These embryos showed no significant phenotype in the nasal capsule cartilage.
Correspondingly, lineage tracing with Gli1-CreERT2 and expression analysis of SHH pathways mem-
bers starting from E11.5 did not show any association with development of facial cartilages.
These cartilage-related results, where SHH-activity was not associated with facial chondrogenic
differentiation, were dramatically different from those observed in palate-forming mesenchymal cells
in the same experimental embryos. Unlike cartilage, the developing palate showed strong activity of
the SHH-signaling reporter GBS-GFP. We also found high expression levels of SHH pathway mem-
bers, including numerous traced progeny in Gli1-CreERT2/R26Tomato animals. As expected, in
embryos treated with Vismodegib between E11.5-E12.5, the palate was almost missing, in contrast
to contrary to the nasal capsule cartilage that stayed virtually intact. The presence of abnormal pal-
ate clefts in Vismodegib-treated and also in Nkx2.2-Cre/Shh floxed/floxed embryos agrees with previ-
ous findings, which have established a general role of SHH in the patterning of the face and in
development of pathological midfacial clefts (Hu and Helms, 1999). Accordingly, ciliopathies and
their animal models often demonstrate similar defects (Brugmann et al., 2010; Chang et al., 2016).
Thus, according to our results, SHH is not involved into facial chondrogenesis at stages when
chondrogenic condensations form and convert into mature cartilage. Hence, the role of SHH is most
likely indirect. Presumably, it is involved in the early patterning of facial ectomesenchyme, to create
proper conditions for the sophisticated facial chondrogenesis that will start at later developmental
stages. In line with this reasoning, the mode of action of SHH on chondrogenesis in non-facial loca-
tions, for example, during the development of axial skeleton, is indirect and based on SHH-depen-
dent alterations of cell responses to BMPs in potentially pre-chondrogenic mesenchymal cells.
Murtaugh et al. demonstrated that even a transient SHH signal was able to ensure the competent
chondrogenic response of mesenchymal cells to BMPs (Murtaugh et al., 1999). In the case of the
axial skeleton, such competence-changing action of SHH depends on the initiated and sustained
expression of the transcriptional repressor Nkx3.2, which renders cells responsive to pro-chondro-
genic actions of BMPs (Murtaugh et al., 2001). As shown by Zeng et al., expression of Nkx3.2 is suf-
ficient to induce SOX9, a major chondrogenic master regulator, and in the presence of BMPs,
NKX3.2 and SOX9 could induce the expression of each other (Zeng et al., 2002). Finally, the
sequential action of SHH and BMPs could induce SOX9. According to the public in situ database
Allen Developmental Mouse Brain Atlas (http://developingmouse.brain-map.org), Nkx3.2 shows dis-
tinct expression in a range of cranial cartilages or their future locations at pre-chondrogenic (E11.5)
and chondrogenic (E13.5) stages. The knockout of Nkx3.1 and Nkx3.2 yields changes in the facial
shape, as evident from Figure 1 in Herbrand et al. (Herbrand et al., 2002). Similar patterning effects
of SHH in relation to chondrogenesis have previously been demonstrated during the development
of serial tracheal rings reinforced with cartilage. SHH inactivation in ventral trachea resulted in a lack
of tracheal segmentation which coincided with the loss of cartilage, while the upregulation of Shh
resulted in cartilage overproduction and similar segmentation defects (Sala et al., 2011). Altogether,
this may suggest an analogous or similar mechanism of an indirect action of SHH on craniofacial
chondrogenesis, especially in light of our results showing only minor and sporadic activity of SHH-
signaling reporter in facial chondrogenic condensations or cartilage. Determination of the mecha-
nisms behind SHH action in facial chondrogenesis, with a special focus on the position of the SHH-
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signal in the hierarchy of events leading to chondrogenic differentiation, is a key future direction.
We anticipate that Single cell transcriptomics approaches (Picelli et al., 2013) will be applied to
facial mesenchymal populations prior and during chondrogenesis. This should resolve cell signaling
cascades with high precision along the developmental timeline, in similarity to pioneering studies uti-
lizing this methodology in other tissue types (Furlan et al., 2017).
Complementary to the ablation of Shh by Nkx2.2-Cre, the loss of the olfactory epithelium in Six1/
Six4 double knockout mutants leads to the absence of the nasal capsule roof, while the nasal septum
cartilage stays largely in place. Our data indicate that the loss of a nasal capsule roof in the double
knockout condition is driven by the loss of nasal placodes (requiring both SIX1 and SIX4), which
causes a collapse of olfactory epithelium. Despite the specific loss of nasal capsule roof, other carti-
lages appeared intact in locations corresponding to the expression sites of Six1 and Six4 (including
Meckel’s cartilage). The perfect match between the shape of cartilaginous olfactory turbines and the
epithelium, as well as the coordinated time course of their development (Kaucka et al., 2017), addi-
tionally support the notion that signals from the developing olfactory epithelium might enable the
induction of adjacent cartilage. Still, these arguments cannot completely rule out the possibility that
co-expressed Six1 and Six4 may have early roles during neural crest migration and early post-neural
crest stages that might be important for the nasal roof formation. Taken together, our results pro-
vide strong support for the idea that a single solid cartilaginous element such as the nasal capsule
can be induced by the combinatorial action of signals derived from several, in the present case, neu-
ral and neurosensory, locations. Notably, facial chondrogenic condensations are induced being ‘pre-
shaped’. Already at the earliest steps, they are laid down as highly complex 3D-geometries
(Kaucka et al., 2017). The induction of such 3D-shapes is unlikely to be achieved by signals from a
single site and might require more sources including spatially opposed brain and olfactory struc-
tures. Since we were unable to validate that SHH from the olfactory placode or epithelium is the key
factor that induces a nasal capsule roof, we cannot exclude that other signaling molecules partici-
pate during critical steps of facial cartilage induction. This will require further investigations.
During evolution of vertebrates, cartilages forming the neurocranium and the future upper jaw
appear before Meckel’s cartilage attains a function of a lower jaw skeleton, and the animals acquire
articulated hinged jaws (Shimeld and Donoghue, 2012). Therefore, one of the primeval functions of
the neurocranial and frontal cartilages could be the encasement and protection of the neural and
sensory compartments such as brain, eyes, ears and olfactory neurons. If that is the case, it is logical
to reason that these neurosensory structures could emit cartilage-inducing signals and coordinate
cartilage growth and shaping. Our experimental results reveal the key role of SHH from the develop-
ing brain in enabling the induction of a nasal capsule and basicranial cartilages, and, thus, support
the aforementioned evolutionary hypothesis. The capacity of the developing olfactory epithelium to
shape the cartilaginous support also favors this reasoning. Genetics-based prevention of neuronal
differentiation in the olfactory epithelium (vial Ascl1 knockout) does not interfere with shaping of the
nasal capsule and confines the shaping role of presumably olfactory progenitors to the developmen-
tal period before their differentiation into the mature olfactory neurons. Alternatively, other cell
types in the olfactory epithelium may play a cartilage-inducing role (olfactory glia, non-neurogenic
epithelium).
In addition to the evolutionary aspect, the role of different neurosensory structures (mainly the
brain) in coordinated cartilage induction may suggest a new connection between neurological and
craniofacial symptoms in numerous genetic syndromes. Examples of such conditions are Williams
syndrome, Down syndrome and others that are manifested by behavioral and morphological abnor-
malities in the central nervous system (Starbuck et al., 2017; Weisman et al., 2017; Vincent et al.,
2014; Antshel et al., 2008) (and reviewed by [Marcucio et al., 2011]). Based on this reasoning, it is
possible to envision a mechanistic connection between the fine aspects of a facial geometry and
individual features of the human brain. An enormous facial variability is found among humans, which
poses a question regarding the molecular and cellular mechanisms that underlie this variability. In
difference to humans, non-human primates generally use variations in colored facial hairs to express
their species, social status and sex in addition to body movements, voice expressions and scent
(Santana et al., 2012; Allen and Higham, 2015). This brings us to speculate whether the loss of
dense facial hairs during evolution of humans led to the development of a very broad range of vari-
ous facial tissue-related features in order to compensate for the loss of facial hair-related communi-
cation and individual recognition. We hypothesize that one of those shape-tuning mechanisms could
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include flexible and individual modulation of SHH, an important patterning and shaping agent during
the embryonic development that comes from different spatial sources including the developing
brain.
Previous research has established the existence and position of some of the specific regulatory
elements that direct the expression of Shh in the craniofacial epithelial linings (MRCS1 and MFCS4,
see (Sagai et al., 2009) for details) as well as in the floor plate and anterior forebrain (SBE2 ((Shh
Brain Enhancer 2)), SBE3 and SBE4 [Yao et al., 2016; Jeong et al., 2006]). In order to find out fine
effects in facial cartilages as a result of activity by site-specific enhancers, we analyzed a variety of
mutants with deleted and inverted genomic regions containing such regulatory elements (mutants
created by Franc¸ois Spitz’ laboratory [Symmons et al., 2016]). The inversion of the  500 C1 geno-
mic region including known CBEs showed localized defects within the nasal septum that incremen-
tally increased from heterozygous to homozygous state without influencing nasal capsule roof
shape. Similarly, the inversion of (6b-C2) region in a heterozygous state caused minor defects in sep-
tum, whereas the same inversion on the background of deletion of the entire regulatory region ( 90
C2) appeared similar to ShhHypo or even Shh knock out. This is explained by the translocation of
TAD (see (Symmons et al., 2016) for details) and resulting ‘isolation’ of Shh coding part from head-
specific regulatory regions located between positions six and C2. In this latter case (INV(6b-C2)), Shh
expression was dramatically reduced in the anterior forebrain as compared to the control
(Symmons et al., 2016).
Further analysis of more restricted Shh regulatory regions revealed that brain-specific and facial
cartilage-related enhancers are confined within the region (5-8) and are at least partly responsible
for the expression of Shh in the forebrain according to the loss of in situ hybridization signal in the
forebrain of (DEL(5-8)) compared to controls. The deletion of this (DEL(5-8)) region resulted in severe
facial malformation and collapse of the nasal capsule shape to the state resembling ShhHypo. Despite
that we clearly observed the misshaped nasal capsule roof in these embryos, the septum was
completely gone similarly to (DEL( 90 C2) x INV (6b-C2)) mutants. Taken together, these results
provide strong support to the discrete role of genomic regulatory regions directing the expression
of Shh to the forebrain and, through this, affecting the patterning of septal, basicranial and other
cartilages in the head.
Importantly, all analyzed embryos carrying mutated regulatory regions never demonstrated miss-
ing nasal capsule roof including severe (DEL( 90 C2) x INV (6b-C2)), (DEL (5-8) HOMO) and ShhHypo.
This might mean that we still do not know about the position of the corresponding regulatory
regions targeting the expression of Shh to the olfactory epithelium or FEZ in the frontal face. The
loss or inversion of regulatory regions resulting in mild septal defects did not affect the anterior nasal
capsule, which might be independently patterned by FEZ. Similarly, the morphology of the anterior
nasal capsule stayed relatively stable when septal cartilage disappeared in Nkx2.2-Cre/Shh floxed/
floxed animals. This suggests that the most anterior face including frontal facial cartilages might be
indeed patterned by FEZ together with olfactory placodes independently from brain-derived signals.
These results point towards the possibility that mouse FEZ can form and act independently of the
CNS signaling center contrary to chick embryonic development (Hu and Marcucio, 2009).
To summarize, it is possible that enhancer-dependent spatial and temporal regulations of Shh
expression could be evolutionary tools to achieve the impressive variety of facial cartilage shapes in
humans - a basis for facial individuality. Indeed, much attention has been focused on the role of
enhancers in craniofacial evolution. Recently, by applying a combination of morphometry, molecular
biology and mouse genetics, Attanasio et al. described numerous enhancers that are differentially
active and take part in the development of a facial shape (Attanasio et al., 2013). In line with this,
mutations in the enhancers that control the expression of Fgf8, another cartilage-inducing factor
(Abzhanov and Tabin, 2004), also result in geometrical abnormalities of the nasal capsule
(Marinic´ et al., 2013). It seems that many genes and pathways are involved in shaping the face
(Young et al., 2014; Hu et al., 2015a; Foppiano et al., 2007; Hu et al., 2015b). This is not surpris-
ing, since the facial shaping includes many stages that are pre-chondrogenic, chondrogenic (includ-
ing induction, growth, remodeling of the cartilage) and osteogenic. Processes of isotropic and
anisotropic growth of the skeletal structures also play important roles in achieving the final geometry
of the facial region (Kaucka et al., 2017). Despite such complexity and the enormous degree of spa-
tio-temporal integration, the initial induction of cartilage guided by the brain and olfactory epithe-
lium represents a key moment of facial skeleton formation. It may well also be an evolutionary
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substrate driving the diversity of faces and snouts. Consequently, the fine-tuning of patterning and
cartilage-inducing signals in neurosensory structures deserves further attention, including explora-
tions of the diversity of corresponding genetic regulatory regions in human and animal genomes.
Materials and methods
Key resources table
Reagent type species
or resource Designation Source or reference Identifiers Additional information
Strain Col2a1-CreERT2 Nakamura et al. (2006) Received from
S. Mackem
Strain R26Confetti https://www.jax.org/strain/013731 Received from
H. Clevers
Strain R26DTA Voehringer et al. (2008) Received from
Jackson
Strain Six1 KO Grifone et al. (2005) Received from
P. Maire
Strain Six1/4 double KO Grifone et al. (2005) Received from
P. Maire
Strain Nkx2.2-Cre/Shhflx/flx Yu et al., 2013 Received from
M. Matise
Strain Ascl1 (Mash1) Cau et al. (1997) Received from
U. Marklund
Strain B6.Cg-Shhtm1EGFP/creCjt/J Harfe et al. (2004) Received from
M. Hovorakova
Strain Gli1-CreERT2 https://www.jax.org/strain/007913 Received from
M.Kasper
Strain Gli1-lacZ https://www.jax.org/strain/008211 Received from
M.Kasper
Strain Shh-GFP https://www.jax.org/strain/008466
(Chamberlain et al., 2008)
Received from
Jackson
Strain TgGBS-GFP Balaskas et al. (2012) Received from
A. Kicheva
Strain Rosa-CAG-LSL-tdTomato
-WPRE
https://www.jax.org/strain/007914 Received from
M. Kasper
Strain INV-500-C1 F. Spitz (Symmons et al., 2016) Received from
F. Spitz
Strain INV6b-C2 F. Spitz (Symmons et al., 2016) Received from
F. Spitz
Strain Del-90-C2 F. Spitz (Symmons et al., 2016) Received from
F. Spitz
Strain DELC1-Z F. Spitz (Symmons et al., 2016) Received from
F. Spitz
Strain DEL5-8 F. Spitz (Symmons et al., 2016) Received from
F. Spitz
Antibody SOX9 Sigma Aldrich, HPA001758 one to 1000 in PBS-T
over night at RT
Antibody ERBB3 RnD Systems, AF4518 one to 500 in PBS-T
over night at RT
Drug Vismodegib LoRusso et al. (2011) 0.1 mg/kg
Software IMARIS http://www.bitplane.com/
Software GOM Inspect https://www.gom.com/de/3d-
software/gom-inspect.html
Software VGStudio Max https://www.volumegraphics.com
/en/products/vgstudio-max.html
Continued on next page
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Continued
Reagent type species
or resource Designation Source or reference Identifiers Additional information
RNAscope probes Gli1 (311001), Gli2 (405771),
Gli3 (445511), Smo (318411),
Ptch1 (402811) and Ptch2
(435131)
https://acdbio.com/rnascope%C2%
AE-technology-novel-rna-situ-
hybridization-research-platform
Mouse strains and animal information
All animal work were approved and permitted by the Local Ethical Committee on Animal Experi-
ments (North Stockholm Animal Ethics Committee) and conducted according to The Swedish Animal
Agency´s Provisions and Guidelines for Animal Experimentation recommendations. Genetic tracing
mouse strain Nkx2.2-Cre was described previously (Yu et al., 2013). Col2a1-CreERT2 (Ozaki et al.,
2001) (obtained from the laboratory of S. Mackem, NIH) strains (Nakamura et al., 2006) were cou-
pled to R26Confetti mice that were received from the laboratory of Professor H. Clevers
(Snippert et al., 2010). DTA strain (Voehringer et al., 2008) (B6.129P2-Gt(ROSA)26Sortm1(DTA)
Lky/J, The Jackson Laboratory) was coupled to Col2a1-CreERT2. Six1 and Six1/4 double KO
embryos were generated as described already (Grifone et al., 2005; Laclef et al., 2003). Nkx2.2-
Cre/Shhflx/flx embryos were received from the laboratory of Michael Matise. Ascl1 (Mash1) KO
embryos were received from the laboratory of Ulrika Marklund. B6.Cg-Shhtm1(EGFP/cre)Cjt/J
(Harfe et al., 2004) embryos were received from the laboratory of Maria Hovorakova (CAS). Gli1-
CreERT2 and Gli1-lacZ strains were obtained from the laboratory of Maria Kasper (Karolinska Institu-
tet). Gli1-CreERT2 was coupled with R26Confetti and R26Tomato.
The following strains were previously described: Tg(GBS-GFP) (Balaskas et al., 2012), Shh-GFP
(JAX stock #008466 (Chamberlain et al., 2008). ShhHypo embryos are homozygous for Shh-GFP and
their morphological phenotypes are not affected by the presence or absence of the Tg(GBS-GFP)
transgene. Strains were bred and maintained on 129/Sv background, in accordance with license
BMWFW-66.018/0006-WF/V/3b/2016 granted by the Austrian BMWFW.
Gli1-LacZ (https://www.jax.org/strain/008211), Gli1-CreERT2 (https://www.jax.org/strain/007913)
and Rosa-CAG-LSL-tdTomato-WPRE (https://www.jax.org/strain/007914) were used under the ethi-
cal permit: number S40/13, granted by South Stockholm Animal Ethics Committee.
Mice of the relevant genotype were mated overnight, and noon of the day of the plug was con-
sidered as E0.5. To induce genetic recombination of adequate efficiency, pregnant females of rele-
vant couplings were injected intraperitoneally with tamoxifen (Sigma T5648) dissolved in corn oil
(Sigma C8267). Tamoxifen concentration ranged from 1.5 to 5.0 mg per animal to obtain a range of
recombination efficiency. Mice were sacrificed with isoflurane (Baxter KDG9623) overdose or cervical
dislocation, and embryos were dissected out and collected into ice-cold PBS. Subsequently, the sam-
ples were placed into freshly prepared 4% paraformaldehyde (PFA) and depending on the develop-
mental stage and the application they were fixed for 3–24 hr at 4˚C on a roller. Subsequently, for the
purpose of microscopy analysis, the embryos were cryopreserved in 30% sucrose (VWR C27480)
overnight at 4˚C, embedded in OCT media (HistoLab 45830) and cut into 18 mm to 30 mm sections
on a cryostat (Microm). Embryos designated for CT analysis were then stained according to the pro-
tocol described beneath.
Inhibition of hedgehog signaling
In order to inhibit SHH during embryonic development (stages E11.5 to E13.5), the pharmacological
inhibitor Vismodegib (LoRusso et al., 2011) was injected intraperitoneally at a dosage of 0.1 mg per
g of bodyweight of the pregnant mouse. Embryos were collected at E15.5 and fixed in 4% formalde-
hyde in PBS solution for 24 hr at +4˚C with slow rotation.
Histological staining
Slides were stained for mineral deposition using von Kossa calcium staining: 5% silver nitrate solution
was added to the sections at a room temperature and exposed to strong light for 30 min. After that
the silver nitrate solution was removed, and slides were washed with distilled water for 3 times dur-
ing 2 min. 2.5% sodium thiosulphate solution (w/v) was added to the sections and incubated for five
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mins. Slides were again rinsed for 3 times during 2 min in distilled water. The sections were then
counterstained using Alcian blue. Alcian blue solution (0.1% alcian blue 8GX (w/v) in 0.1 M HCl) was
added to the tissue for 3 min at room temperature and then rinsed for 3 times during 2 min in dis-
tilled water. Slides were then transferred rapidly into incrementally increasing ethanol concentrations
(20%, 40%, 80%, 100%) and incubated in 100% ethanol for 2 min. Finally, the slides were incubated
in two xylene baths (for 2 min and then for 5 min) before mounting and analysis.
Immunohistochemistry, histological staining and EdU analysis
Frozen samples were sectioned at 18–30 mm depending on specific experiment. If needed, sections
were stored at  20˚C after drying 1 hr at room temperature, or processed immediately after section-
ing. Primary antibodies used were: chicken anti-GFP (Abcam, 1:500, ab13970), rabbit anti-SOX9
(Sigma Aldrich, 1:1000, HPA001758), sheep anti-ERBB3 (RnD Systems, 1:500, AF4518). For detection
of above-mentioned primary antibodies, we utilized 405, 488, 555 or 647-conjugated Alexa second-
ary antibodies produced in donkey (Invitrogen, 1:1000). Slices were mounted with 87% glycerol
mounting media (Merck).
Fluorescent in situ hybridization (RNAscope)
E12.5 and E13.5 embryos were collected, embedded immediately in OCT and snap frozen on dry
ice. Tissue blocks were stored at  20˚C until further use. 8-mm-thick cryosections were collected on
Superfrost Plus slides and stored at  20˚C until further use. Fluorescent in situ hybridization was per-
formed for the genes Gli1 (311001), Gli2 (405771), Gli3 (445511), Smo (318411), Ptch1 (402811) and
Ptch2 (435131) using the RNAscope 2.0 Assay, reagents and probes according to manufacturer’s
instructions (Wang et al., 2012). RNAscope probes were designed commercially by the manufac-
turer and are available from Advanced Cell Diagnostics, Inc. being protected by patent.
X-gal staining
E11.5, E12.5 and E13.5 embryos were fixed in 4% formaldehyde in PBS solution for 2–3 hr at +4˚C
with slow rotation. Following washes with PBS, embryos were incubated in X-gal staining solution (1
mg/ml X-gal; 2 mM MgCl2; 0.5 M potassium ferrocyanide; 0.5 M potassium ferricyanide in PBS) at
37˚C, overnight, with gentle agitation. Samples were washed twice, 20 min each time at room tem-
perature in PBS and imaged whole mount. When necessary, we proceeded to cryoprotection in 30%
sucrose in PBS and embedding in OCT medium.
Microscopy, volume rendering, image analysis and quantifications
Confocal microscopy was performed using Zeiss LSM880Airyscan CLSM instruments. The settings
for the imaging of Confetti fluorescent proteins were previously described (Snippert et al., 2010).
Image analysis has been performed using IMARIS Software (Bitplane, Zurich, Switzerland). Before
performing manual segmentations of cartilages and mesenchymal chondrogenic condensations on
all representative samples, we assessed the phenotype and the stability of the phenotype using anal-
ysis of multiple embryos (typically 3–5 per condition) on histological sections as well as whole-mount
assessments of facial morphology and including usage of tomographic slices. In case the phenotype
was stable, the representative embryos underwent 3D segmentation process, otherwise we manually
segmented facial cartilage and bone from all experimental embryos (in case of Col2a1-CreERT2/
R26DTA or ShhHypo, please see Figure 1—figure supplement 1 and Figure 6—figure supplement
3). For embryonic day E17.5 Col2a1-CreERT2/R26DTA, we performed segmentations of the most
affected embryo from the litter (Figure 1I–P and graph in R). Other litter mates were analyzed using
cryo-sections only (Figure 1E–H). Since we did not investigate fine differences in shape of the nasal
capsule and rather concentrated on missing structures (septum or nasal capsule roof), we did not
analyze fine shape differences morphometrically in a quantitative way. In special cases, where rele-
vant, we utilized shape fitting analysis using GOM Inspect tool. We did not use any special randomi-
zation or masking of embryos during experimental and control group allocations.
Tissue contrasting for m-CT scanning
Staining protocol has been adapted and modified from the original protocol developed by Brian
Metscher laboratory (Metscher, 2009). After embryo dissection in ice-cold PBS, the samples were
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fixed in 4% formaldehyde in PBS solution for 24 hr at +4˚C with slow rotation. Subsequently, samples
were dehydrated in incrementally increasing ethanol concentrations (30%, 50%, 70%), 1 day in each
concentration to minimize the shrinkage of the tissue. Samples were transferred, depending on the
embryonic stage, into 1.0–1.5% PTA (phospho-tungstic acid) in 90% methanol for tissue contrasting.
The PTA-methanol solution was changed every 2–3 days. E12.5 embryos were stained for 7 days,
E15.5 embryos for 3 weeks and E18.5 embryos for 7 weeks. The contrasting procedure was followed
by rehydration of the samples by incubation in ethanol series (90%, 70%, 50% and 30%) and shipped
to the CT-laboratory for scanning. There the rehydrated embryos were embedded in 0.5% agarose
gel (A5304, Sigma-Aldrich) and placed in polypropylene conical tubes (0.5, 1.5 or 15 ml depending
on the sample size to minimize the amount of medium surrounding it) and to avoid the movement
artifacts during X-ray computer tomography scanning.
m-CT analysis (micro computed tomography analysis) and 3D analysis
The m-CT analysis of the embryos was conducted using the laboratory system GE phoenix v|tome|x L
240 (GE Sensing and Inspection Technologies GmbH, Germany), equipped with a 180 kV/15W maxi-
mum power nanofocus X-ray tube and flat panel detector DXR250 with 2048  2048 pixel,
200  200 mm pixel size. The embryos were fixed in polyimide tubes by 1% agarose gel to prevent
tomographic movement artifacts. The exposure time of the detector was 900 ms in every of 2000
positions. Three projections were acquired and averaged for reduction of the noise in m-CT data.
The utilized power of the tube was 11 W given by acceleration voltage of 60 kV and tube current of
200 mA. X-ray spectrum was filtered by 0.1 mm of aluminium plate. The voxel size of obtained vol-
umes (depending on a size of an embryo head) appeared in the range of 5 mm - 7 mm. The tomo-
graphic reconstructions were performed using GE phoenix datos|x 2.0 3D computed tomography
software (GE Sensing and Inspection Technologies GmbH, Germany). The cartilage in the embryo
head was segmented by an operator with semi-automatic tools within Avizo - 3D image data proc-
essing software (FEI, USA). The 3D segmented region was transformed to a polygonal mesh as a STL
file. The mesh of the embryo head was imported to VG Studio MAX 2.2 software (Volume Graphics
GmbH, Germany) for consequent modification of the mesh, like a surface smoothing, and 3D visuali-
zation. The software GOM Inspect V8 (GOM, Braunschweig, Germany) was implemented for com-
parisons of full shapes of the head. The triangular meshes of the surface of the heads represented
by STL models were imported into the software, aligned and compared with parameters of maxi-
mum searching distance 1 mm and maximum opening angle 30˚. All raw STL files are freely accessi-
ble via the following Dryad link: https://doi.org/10.5061/dryad.f1s76f2
The STL format can be opened with Paint 3D or Print 3D software.
Light sheet microscopy and sample clearing
Whole heads from Shh-GFP embryos at E11.5 E12.5, E13.5 and E14.5 were cleared using a modified
CUBIC protocol (Susaki et al., 2014). In brief, embryos were fixed by using 4% PFA in PBS for 4 hr
at four degrees before incubating in CUBIC one solution (25% urea, 25% N,N,N0,N0-tetrakis-(2-
hydroxypropyl) ethylenediamine and 15% Triton X-100) at 37˚C under shaking conditions for 3 days.
Subsequently, the samples were washed in PBS at RT. Next, samples were immersed in CUBIC two
solution (50% sucrose, 25% urea, 10% 2,20,200-nitrilotriethanol, and 0.1% Triton X-100) and left shak-
ing at RT for an additional 2–3 days before image acquisition.
Whole embryo head (E11.5–E14.5) GFP fluorescence images were acquired on a Light sheet Z.1
microscope (Zeiss) using a  5 (EC Plan Neofluar 5/0.16) detection objective,5/0.1 illumination
optics, and laser excitation at 488 nm. Samples were imaged in CUBIC two solution with a measured
refractory index of 1.45. Each plane was illuminated from a single side of the sample. Whole images
were obtained through tile scanning. 3D-rendered images were visualized with Arivis Vision4D for
Zeiss (v. 2.11) or Imaris (v. 7.4.2, Bitplane).
Bitplane IMARIS software was subsequently used for 3D visualization and analysis of the light
sheet tiles. By using the surface option in IMARIS the different parts of Shh-GFP have been
highlighted.
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